Oncotelic Therapeutics, Inc. (OTLC)

USD 0.05

(-25.71%)

Revenue Summary of Oncotelic Therapeutics, Inc.

  • Oncotelic Therapeutics, Inc.'s latest annual revenue in 2023 was 70 Thousand USD , down 0.0% from previous year.
  • Oncotelic Therapeutics, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Oncotelic Therapeutics, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Oncotelic Therapeutics, Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Oncotelic Therapeutics, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Oncotelic Therapeutics, Inc. reported a quarterly revenue of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Revenue Chart of Oncotelic Therapeutics, Inc. (2023 - 1992)

Historical Annual Revenue of Oncotelic Therapeutics, Inc. (2023 - 1992)

Year Revenue Revenue Growth
2023 70 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 1.74 Million USD 0.0%
2019 - USD 100.0%
2018 -100.00 USD 0.0%
2017 -100.00 USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 95 Thousand USD 0.0%
2013 95 Thousand USD -39.1%
2012 156 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD -100.0%
2008 12 Thousand USD 0.0%
2007 12 Thousand USD 0.0%
2006 - USD -100.0%
2005 1000.00 USD -85.71%
2004 7000.00 USD -76.67%
2003 30 Thousand USD -91.03%
2002 334.51 Thousand USD -96.61%
2001 9.86 Million USD 481.73%
2000 1.69 Million USD 33.26%
1999 1.27 Million USD 1171.92%
1998 100 Thousand USD 0.0%
1997 100 Thousand USD 0.0%
1996 100 Thousand USD 0.0%
1995 100 Thousand USD -66.67%
1994 300 Thousand USD 200.0%
1993 100 Thousand USD 0.0%
1992 100 Thousand USD 0.0%

Peer Revenue Comparison of Oncotelic Therapeutics, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD 7.559%
Evofem Biosciences, Inc. 18.21 Million USD 99.616%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.943%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 96.377%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.556%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -297.253%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.674%
Intellipharmaceutics International Inc. 65.72 Thousand USD -6.5%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 98.814%
Marizyme, Inc. 645.81 Thousand USD 89.161%
Genus plc 668.8 Million USD 99.99%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.971%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 29.289%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 82.934%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 8.808%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -77.134%
MultiCell Technologies, Inc. 49.32 USD -141830.251%
ONE Bio Corp. 52.29 Million USD 99.866%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.859%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -43.149%
Q BioMed Inc. 284.35 Thousand USD 75.383%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.763%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.952%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 87.449%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 89.37%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -6907.007%
Enzolytics Inc. 52.79 Thousand USD -32.586%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 88.497%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.994%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 50.086%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 88.662%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.992%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 92.984%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.855%
BioStem Technologies, Inc. 16.68 Million USD 99.58%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 70.409%
Regen BioPharma, Inc. 236.56 Thousand USD 70.409%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 94.887%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 85.224%
SYBLEU INC 11.69 Thousand USD -498.495%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.101%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -438.462%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -77.063%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 97.898%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.95%
IntelGenx Technologies Corp. 1.03 Million USD 93.263%
Gelesis Holdings, Inc. 25.76 Million USD 99.728%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 90.728%